QCG
EVH icon

Quadrant Capital Group’s Evolent Health EVH Stock Holding History

Quadrant Capital Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.5K Buy
18,634
+15,791
+555% +$50.1K ﹤0.01% 1757
2025
Q4 		$11.4K Buy
2,843
+1,412
+99% +$7.85K ﹤0.01% 2171
2025
Q3 		$12.1K Buy
+1,431
New +$13.9K ﹤0.01% 2111
2025
Q2 		– Sell
-4,783
Closed -$45.3K – 1749
2025
Q1 		$45.3K Buy
4,783
+4,521
+1,726% +$45.7K ﹤0.01% 1751
2024
Q4 		$2.95K Sell
262
-257
-50% -$4.52K ﹤0.01% 2439
2024
Q3 		$14.7K Buy
519
+485
+1,426% +$12.5K ﹤0.01% 2024
2024
Q2 		$651 Sell
34
-187
-85% -$4.78K ﹤0.01% 2603
2024
Q1 		$7.25K Buy
221
+80
+57% +$2.55K ﹤0.01% 2214
2023
Q4 		$4.66K Buy
141
+36
+34% +$1.02K ﹤0.01% 2292
2023
Q3 		$2.86K Buy
105
+100
+2,000% +$2.78K ﹤0.01% 2300
2023
Q2 		$152 Sell
5
-4
-44% -$129 ﹤0.01% 2668
2023
Q1 		$293 Buy
9
+4
+80% +$126 ﹤0.01% 2652
2022
Q4 		$140 Sell
5
-149
-97% -$4.27K ﹤0.01% 2713
2022
Q3 		$6K Hold
154
– – ﹤0.01% 2066
2022
Q2 		$5K Buy
+154
New +$4.49K ﹤0.01% 1955
2020
Q2 		– Sell
-1,000
Closed -$5K – 2270
2020
Q1 		$5K Hold
1,000
– – ﹤0.01% 1639
2019
Q4 		$9K Hold
1,000
– – ﹤0.01% 1920
2019
Q3 		$7K Buy
+1,000
New +$7.18K ﹤0.01% 1847
2017
Q4 		– Sell
-250
Closed -$4K – 2120
2017
Q3 		$4K Hold
250
– – ﹤0.01% 1530
2017
Q2 		$6K Buy
+250
New +$6.01K ﹤0.01% 1272

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrant Capital Group's EVH Position: Q1 2026 in Review

Quadrant Capital Group increased its Evolent Health (EVH) stake by 555% in Q1 2026, buying an estimated $50.1K and bringing the position to 18,634 shares worth $42.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Quadrant Capital Group first reported a position in EVH in Q2 2017 and has held it in 20 quarters since. The position peaked at $45.3K in Q1 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Quadrant Capital Group held 18,634 shares of Evolent Health worth $42.5K as of Q1 2026.
  • Quadrant Capital Group bought 15,791 Evolent Health shares in Q1 2026, an estimated $50.1K.
  • Evolent Health made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1757 holding.
  • Quadrant Capital Group first reported a position in Evolent Health in Q2 2017 and has held it in 20 quarters since.
  • Quadrant Capital Group's Evolent Health position peaked at $45.3K in Q1 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.